Orphan Drugs- development trends and strategies

The development of pharma industries has slowed in recent years because of many reasons such as patent expiries, generic competition, drying pipelines, and increasingly stringent regulatory guidelines. Many blockbuster drugs will lose their exclusivity in next 5 years. Therefore, the current economic situation plus the huge generic competition shifted the focus of pharmaceutical companies from the essential medicines to the new business model — niche busters, also called orphan drugs.

    Related Conference of Orphan Drugs- development trends and strategies

    June 09-10, 2020

    10th European Epidemiology and Public Health Congress

    Istanbul, Turkey
    August 19-20, 2020

    European Summit on HIV, STD and STIs

    Milan, Italy
    September 28-29, 2020

    13th Global Infections Conference

    Singapore
    October 5-6, 2020

    12th Euro-Global Conference on Infectious Diseases

    Vienna, Austria
    November 05-06, 2020

    9th Asia Pacific STD and Infectious Diseases Congress

    Tokyo, Japan
    February 15-16, 2021

    8th International Congress on Infectious Diseases

    London, UK
    February 22-23, 2021

    4th Global Experts Meeting on Infectious Diseases

    Singapore City, Singapore

    Orphan Drugs- development trends and strategies Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in